Team is first in Texas to join NIH-sponsored study investigating efficacy of convalescent plasma for COVID-19
Using a multimillion-dollar grant from the National Institutes of Health, physician-scientists McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country. As part of the Center for Clinical […]
When a crisis occurs, you can almost bet on the health care industry to respond without hesitation to provide support for those in need. Facing the same worries about the COVID-19 pandemic as the rest of the population, medical professionals around the world showed no fear in coming together to provide care and help battle […]
The Departments of Anesthesiology and Emergency Medicine at McGovern Medical School have been approved for a phase-2 clinical trial to study the effects of a drug to potentially treat COVID-19 patients. The clinical trial is a collaboration with Akebia Therapeutics Inc. “We are all very excited about this opportunity,” said Holger K. Eltzschig, MD, PhD, […]
COVID-19 patient at LBJ Hospital recovers after convalescent plasma transfusion
More than a month after her battle with COVID-19, Kony Chacon enjoys spending time with newborn daughter and shows no ill effects from the virus that jeopardized her life and that of her unborn child. She credits a century-old treatment now being used to help coronavirus patients fight off the infection – convalescent blood plasma […]
Anjail Sharrief, MD, MPH, associate professor of neurology and director of stroke prevention for the Institute of Stroke and Cerebrovascular Disease, recently was appointed to a citywide COVID-19 response task force. Established by Houston Mayor Sylvester Turner, the Health Equity Response (H.E.R.) Initiative and Task Force was launched in April 2020 as an intervention for […]
UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm
A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital. The Phase III, […]
Planes, trains and automobiles: reducing the risks of traveling this summer
After enduring more than two months of quarantine, businesses and institutions are reopening, spurring summer travel plans to satisfy the urge to escape confinement. But is it safe to travel with the threat of COVID-19 still lingering? Experts at UT Physicians and The University of Texas Health Science Center at Houston (UTHealth) weigh in on how to […]
Watch out for signs of mental illness in teens as a result of current events
The coronavirus pandemic, coupled with recent headlines of injustice, riots, racial tension, and protests, has surfaced feelings of anxiety and depression in adults, but young people are no doubt feeling the impact as well. “Mental illnesses are on the rise across the board,” said Amalia Guardiola, MD, associate professor in the Department of Pediatrics at McGovern […]
McGovern Medical School students step up to relieve burdens for front line physicians
“I swim in hot weather,” said 6-year-old Owen McKay during his virtual tutoring session with Caroline Andrews, a student of McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). Just a few weeks ago, the “s” sound in “swim” and “th” sound in “weather” were difficult to pronounce for Owen, who […]
Autopsy research aims to advance COVID-19 knowledge
In an effort to continue fighting the global COVID-19 pandemic, a team of pathologists from McGovern Medical School has documented the pathological findings from 23 autopsy patients with the disease in an upcoming issue of Cardiovascular Pathology, now published on line and available on ScienceDirect. The paper titled “The emerging spectrum of cardiopulmonary pathology of […]